🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2026-526264-20-00
Authorised Phase I

Study of GS-2426 in Participants With Advanced Solid Tumors

2026-526264-20-00 · tracked via the Priya Life Science EU tracker
Sponsor
Gilead Sciences Inc.
Sponsor type
Pharmaceutical company
Therapeutic area
Neoplasms
Decision date
07/09/2026
Enrollment target
37
Sites
Spain

Condition studied

MTAP-Deleted Advanced Solid Tumors

Eligibility

Age group
65+ years, 18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2026-526264-20-00 on CTIS ↗ ← All trials in the EU